European Commissioner Joaquin Almunia has reportedly confirmed that he is “gathering information” regarding allegations that pharmaceutical giants Roche Holding and Novartis colluded to prevent the sale of an eye disease treatment in favor of selling the treatment’s more expensive counterpart.
Almunia answered reporter questions Monday and confirmed that the Commission would “assess whether further action is needed” regarding the matter, but declined to elaborate. A formal investigation has not been opened.
Italian regulators fined the companies more than $254 million in 2012 for similar allegations. Italy’ antitrust regulator sanctioned the firms after finding that the companies colluded to block eye disease medicine Avastin so a more expensive drug, Lucentis, could be sold. The companies jointly market for Lucentis.
Novartis is appealing Italy’s decision.
Almunia told reporters, however, that the case in Italy will not impact the Commission’s actions on the matter, and does not necessarily indicate similar anticompetitive conduct by the companies in other EU member states.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
College Sports Leaders in Intensive Talks to Settle NIL Antitrust Case Against NCAA
Apr 30, 2024 by
CPI
EU Investigates Facebook’s and Instagram’s Handling of Disinformation Ahead of Elections
Apr 30, 2024 by
CPI
Antitrust Lawsuit Targets Hotel Giants for Alleged Price Fixing with AI
Apr 30, 2024 by
CPI
ABA Seeks to Join FTC Lawsuit Against Amazon Over Antitrust Concerns
Apr 30, 2024 by
CPI
Google Agrees to Pay News Corp for AI-Related Content
Apr 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI